CompoAtlas

維納銀補膜衣錠狀食品

維納銀補膜衣錠狀食品 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
BETA CAROTENEBETA CAROTENEBêta-carotène
VITAMIN C (ASCORBIC ACID)VITAMIN C (ASCORBIC ACID)Vitamine C
VITAMIN D3 (CHOLECALCIFEROL)VITAMIN D3 (CHOLECALCIFEROL)Vitamine D
VITAMIN E (DL-ALPHA-TOCOPHERYL ACETATE)VITAMIN E (DL-ALPHA-TOCOPHERYL ACETATE)Vitamine E
VITAMIN K1 (PHYLLOQUINONE)VITAMIN K1 (PHYLLOQUINONE)Vitamine K
VITAMIN B1 (THIAMINE HYDROCHLORIDE)VITAMIN B1 (THIAMINE HYDROCHLORIDE)Vitamine B1 (thiamine)
VITAMIN B2 (RIBOFLAVIN)VITAMIN B2 (RIBOFLAVIN)Vitamine B2 (riboflavine)
VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)Vitamine B6
VITAMIN B12 (CYANOCOBALAMIN)VITAMIN B12 (CYANOCOBALAMIN)Vitamine B12
FOLIC ACIDFOLIC ACIDFolates (vitamine B9)
CALCIUM PANTOTHENATECALCIUM PANTOTHENATEAcide pantothénique (vitamine B5)
NICOTINAMIDENICOTINAMIDENicotinamide (vitamine B3)
BIOTINBIOTINBiotine (vitamine B8)
CALCIUM CARBONATECALCIUM CARBONATECalcium
CALCIUM PHOSPHATE DIBASICCALCIUM PHOSPHATE DIBASICCalcium
FERROUS FUMARATEFERROUS FUMARATEFer
MAGNESIUM OXIDEMAGNESIUM OXIDEMagnésium
ZINC OXIDEZINC OXIDEZinc
POTASSIUM IODIDEPOTASSIUM IODIDEIode
COPPER SULFATECOPPER SULFATECuivre
MANGANESE SULFATEMANGANESE SULFATEManganèse
CHROMIUM YEASTCHROMIUM YEASTChrome
SELENIUM YEASTSELENIUM YEASTSélénium
POTASSIUM CHLORIDEPOTASSIUM CHLORIDEPotassium
SILICON DIOXIDESILICON DIOXIDENot identified
LUTEINLUTEINNot identified
TOMATOES POWDERTOMATOES POWDERNot identified
SAFFLOWER SEED OILSAFFLOWER SEED OILNot identified
MALTODEXTRINMALTODEXTRINMaltodextrine
TAURINETAURINETaurine
SOY LECITHINSOY LECITHINNot identified
BROMELAINBROMELAINNot identified
BREWER'S YEASTBREWER'S YEASTNot identified
MICROCRYSTALLINE CELLULOSEMICROCRYSTALLINE CELLULOSENot identified
MAGNESIUM STEARATEMAGNESIUM STEARATENot identified
STEARIC ACIDSTEARIC ACIDAcide stéarique
D-SORBITOLD-SORBITOLNot identified
ALLURA RED ACALLURA RED ACNot identified
INDIGO CARMINEINDIGO CARMINENot identified
TITANIUM DIOXIDETITANIUM DIOXIDENot identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
1096608079
Chinese name
維納銀補膜衣錠狀食品
English name
VINAYU-P FILM TABLET
Type
Imported tablets and capsules
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
科芳貿易有限公司
Registration date
2020-09-07
Published validity end
2030-09-07

Original register data

View published fields and their variants
Product name
維納銀補膜衣錠狀食品
Active ingredients
BETA CAROTENE;;VITAMIN C (ASCORBIC ACID);;VITAMIN D3 (CHOLECALCIFEROL);;VITAMIN E (DL-ALPHA-TOCOPHERYL ACETATE);;VITAMIN K1 (PHYLLOQUINONE);;VITAMIN B1 (THIAMINE HYDROCHLORIDE);;VITAMIN B2 (RIBOFLAVIN);;VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE);;VITAMIN B12 (CYANOCOBALAMIN);;FOLIC ACID;;CALCIUM PANTOTHENATE;;NICOTINAMIDE;;BIOTIN;;CALCIUM CARBONATE;;CALCIUM PHOSPHATE DIBASIC;;FERROUS FUMARATE;;MAGNESIUM OXIDE;;ZINC OXIDE;;POTASSIUM IODIDE;;COPPER SULFATE;;MANGANESE SULFATE;;CHROMIUM YEAST;;SELENIUM YEAST;;POTASSIUM CHLORIDE;;SILICON DIOXIDE;;LUTEIN;;TOMATOES POWDER;;SAFFLOWER SEED OIL;;SAFFLOWER SEED OIL;;MALTODEXTRIN;;SILICON DIOXIDE;;TAURINE;;SOY LECITHIN;;BROMELAIN;;BREWER'S YEAST;;MICROCRYSTALLINE CELLULOSE;;MAGNESIUM STEARATE;;STEARIC ACID;;D-SORBITOL;;ALLURA RED AC;;INDIGO CARMINE;;TITANIUM DIOXIDE;;
Valid until
1190907
Registration number
1096608079
Licence holder
科芳貿易有限公司
Registration date
1090907
Published reference
DHC0A966080795
Published English name
VINAYU-P FILM TABLET

Official source

View the official register, number 1096608079

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • VITAMIN D3 (CHOLECALCIFEROL)
    Read the warning, when it applies and the studies cited

    VITAMIN D (>1,000 - 2,500 IU)

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products except products containing zinc sourced from picolinate requiring a contraindication.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).

    Sources cited by Health Canada (2)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).

    Sources cited by Health Canada (3)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NNHPD 2021. Natural and Non-Prescription Health Products Directorate. Internal evidence and HC's product monographs.
    • DPSNSO 2021. Direction des produits de santé naturels et sans ordonnance. Preuves internes et monographies de produits internes de SC.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.

    Applies to products containing vitamin K2.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).

    Sources cited by Health Canada (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Applies to products providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).

    Sources cited by Health Canada (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Contraindications

    Condition of application: All products.

    Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).

    Sources cited by Health Canada (2)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

    Applies to products containing zinc sourced from picolinate.

    Do not use if you are pregnant or breastfeeding (NNHPD 2026).

    Sources cited by Health Canada (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Known adverse reactions

    Condition of application: All products.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).

    Sources cited by Health Canada (2)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

    Applies to products providing more than 350 mg of magnesium per day.

    When using this product you may experience diarrhea (NNHPD 2026).

    Sources cited by Health Canada (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Health Canada monograph dated 26 June 2026

  • TAURINE
    Read the warning, when it applies and the studies cited

    TAURINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).

    Sources cited by Health Canada (2)
    • López Ramón Y Cajal C, Ocampo Martínez R, Couceiro Naveira E, Martínez M. Amino acids in amniotic fluid in the 15th-16th weeks of gestation and preterm labor. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2007;20(3):225-231.
    • Seghieri G, Tesi F, Bianchi L, Loizzo A, Saccomanni G, Ghirlanda G, Anichini R, Franconi F. Taurine in women with a history of gestational diabetes. Diabetes Research and Clinical Practice 2007;76(2):187-192. PubMed

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “維納銀補膜衣錠狀食品”, https://compoatlas.com/en/supplements/taiwan/1096608079-vinayu-p-film-tablet, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line